Why Strawberry Jam Is More Regulated Than Cigarettes

Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Respiratory / Asthma;  Smoking / Quit Smoking;  Public Health
Article Date: 31 Aug 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

While jams and other consumer products are strictly regulated and are required to pass stringent tests before they can be sold, tobacco has no restrictions and manufacturers can, and do, add anything they want into the product.

Published in Respirology by Wiley-Blackwell, the invited editorial "Regulation of Consumer Products: The Bizarre Case of Strawberry Jam and Cigarettes" discusses the issues surrounding tobacco regulations and how the industry could be more effectively governed.

"The establishment of regulation is a political process and occurs slowly. However, with the gradual but prolonged and massive epidemic of tobacco-related diseases, regulation of the industry's products - specifically the constituents of tobacco smoke - has to begin now", says author Dr. Nigel Gray, member of the World Health Organization's (WHO) Tobacco Regulation Study Group.*

Despite the complexities of regulating cigarette manufacturing, the Tobacco Regulation Study Group, or TobReg, has proposed practical means to begin the progressive process of tobacco regulation. As a first step, it has suggested setting mandatory levels for some of the major carcinogens and toxicants in cigarettes. In addition, regular reviews must also be conducted as initial toxin levels are considered generous by industry standards for many countries.

"There is no need for an expensive bureaucracy to oversee this regulation. Countries can simply mandate TobReg's recommendations and publicize them as advice from the world's central public health board. Countries without cigarette manufacturing facilities can simply refuse to import cigarette that do not meet these standards", says Dr. Gray.

He adds, "International standards are highly desirable as large amounts of cigarettes are traded between countries with differing national standards. It is timely for WHO to set standards and offer world leadership - particularly as their Framework Convention on Tobacco Control is now in its implementation process, albeit much slower than most public health advocates would desire. Singapore, Australia and New Zealand are ideally placed to pioneer the introduction of these measures."

This paper will be published in the September 2008 issue of Respirology (Vol. 13, Issue 6). * Disclosure of Interest: The author is a member of the World Health Organization (Who) Tobacco Regulation Study Group.

About Respirology Respirology is a journal of international standing, publishing peer-reviewed articles of scientific excellence in clinical and experimental respiratory biology and disease and its related fields of research including thoracic surgery, internal medicine, immunology, intensive and critical care, epidemiology, cell and molecular biology, pathology, pharmacology and physiology.

About Wiley-Blackwell

Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit http://www.blackwellpublishing.com or http://interscience.wiley.com.

About Wiley

Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and understanding for 200 years, helping people around the world meet their needs and fulfill their aspirations. Since 1901, Wiley and its acquired companies have published the works of more than 350 Nobel laureates in all categories: Literature, Economics, Physiology/Medicine, Chemistry and Peace.

Our core businesses include scientific, technical, medical and scholarly journals, encyclopedias, books, and online products and services; professional/trade publishes books, subscription products, training materials, and online applications and websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's Web site can be accessed at http://www.wiley.com. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.

John Wiley & Sons, Inc.